Healthcare -
Biotechnology - NASDAQ - US
$ 0.52
-2.62 %
$ 20.1 M
Market Cap
-0.18
P/E
ATHA - LONG-TERM DEBT
Long-term Debt ATHA - Athira Pharma, Inc.
1.22 M
LAST VALUE
-13.65%
2 YEAR CAGR
11.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR